Shuhui Wang
Wuhan, 430000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Multi-omics Analysis Reveals the Protection of a Quadruple Probiotic Mixture in Experimental Autoimmune Hepatitis.
Journal: Probiotics and antimicrobial proteins
Published: January 27, 2026
Ubiquitin-Conjugating Enzyme E2O Primes Hepatocytes to Restore Immune Tolerance in Autoimmune Hepatitis via Inhibiting Y-Box Binding Protein 1/Interleukin-6 Axis.
Journal: Cellular and molecular gastroenterology and hepatology
Published: August 16, 2025
Serum amyloid A1-induced intrahepatic regulatory T-cell dysfunction drives autoimmune hepatitis progression.
Journal: Hepatology (Baltimore, Md.)
Published: January 21, 2025
Unveiling the interplay between hepatocyte SATB1 and innate immunity in autoimmune hepatitis.
Journal: International immunopharmacology
Published: April 12, 2024
L-lysine supplementation attenuates experimental autoimmune hepatitis in a chronic murine model.
Journal: Experimental animals
Published: August 30, 2023
Capillary leak syndrome presenting as refractory ascites in a patient with lymphoma: A rare case report.
Journal: The Journal of international medical research
Published: May 23, 2023
Sophoricoside attenuates autoimmune‑mediated liver injury through the regulation of oxidative stress and the NF‑κB signaling pathway.
Journal: International journal of molecular medicine
Published: April 25, 2023
Therapeutic Effect of Costunolide in Autoimmune Hepatitis: Network Pharmacology and Experimental Validation.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 17, 2023
Genetic deletion of phosphodiesterase 4D in the liver improves kidney damage in high-fat fed mice: liver-kidney crosstalk.
Journal: Cell death & disease
Published: December 08, 2022
Celastrol Alleviates Autoimmune Hepatitis Through the PI3K/AKT Signaling Pathway Based on Network Pharmacology and Experiments.
Journal: Frontiers in pharmacology
Published: November 16, 2021
Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A.
Journal: Clinical and translational medicine
Published: July 01, 2021
Last Updated: 09/26/2026